Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study
出版年份 2014 全文链接
标题
Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study
作者
关键词
-
出版物
HEPATOLOGY
Volume 60, Issue 4, Pages 1211-1221
出版商
Wiley
发表日期
2014-07-05
DOI
10.1002/hep.27289
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis
- (2015) Srinivasan Dasarathy et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- ‘Corrigendum to “Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease” [Contemp Clin Trials 37 (2) (2014) 301–311]’
- (2014) E. Scorletti et al. Contemporary Clinical Trials
- Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease
- (2014) E. Scorletti et al. Contemporary Clinical Trials
- Role of Docosahexaenoic Acid Treatment in Improving Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease
- (2014) Valerio Nobili et al. PLoS One
- Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease
- (2013) E. Scorletti et al. Annual Review of Nutrition
- Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
- (2013) Giovanni Targher et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
- (2013) Kenneth Cusi et al. JOURNAL OF HEPATOLOGY
- Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish
- (2012) Lucy M Browning et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
- (2012) Lokpal S. Bhatia et al. EUROPEAN HEART JOURNAL
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
- (2012) Naga Chalasani et al. GASTROENTEROLOGY
- The epidemiology, pathogenesis and histopathology of fatty liver disease
- (2012) Adam P Levene et al. HISTOPATHOLOGY
- Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2011) Helen M. Parker et al. JOURNAL OF HEPATOLOGY
- Low dietary fish-oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats
- (2010) Emily L. Slee et al. JOURNAL OF LIPID RESEARCH
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current patterns of diet in community-dwelling older men and women: results from the Hertfordshire Cohort Study
- (2009) Siân Robinson et al. AGE AND AGEING
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Independent effects of physical activity in patients with nonalcoholic fatty liver disease
- (2009) Alexis St. George et al. HEPATOLOGY
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
- (2009) Curtis K. Argo et al. JOURNAL OF HEPATOLOGY
- Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role?
- (2008) M. Dietrich et al. ATHEROSCLEROSIS
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia
- (2008) Feng-Shang Zhu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
- (2007) L. Spadaro et al. DIGESTIVE AND LIVER DISEASE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started